Evidence map›Paper›PMID 41262724›Full record

ArticleEuropean heart journal open2025

Intravascular ultrasound-guided percutaneous coronary intervention in acute coronary syndrome stratified by the TVF-ACS risk score: the IVUS-ACS trial.

Jing Kan, Ziwei Xi, Xiaojuan Zhang, Dandan Cai, Nailiang Tian, Xiaobo Li, Zhizhong Liu, Muhammed Anjum, Ping Xie, Xiang Chen and 13 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in European heart journal open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Jing KanNanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.ORCID https://orcid.org/0000-0002-6268-2954
Ziwei XiCenter for Public Health and Epidemic Preparedness and Response, Peking University, Beijing 102627, China.
Xiaojuan ZhangNanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
Dandan CaiNanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
Nailiang TianNanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
Xiaobo LiNanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
Zhizhong LiuNanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
Muhammed AnjumPunjab Institute of Cardiology, Lahore 54000, Pakistan.
Ping XieGansu Provincial People's Hospital, Lanzhou 730000, China.
Xiang ChenXiamen Heart Center, Xiamen University, Xiamen 361000, China.ORCID https://orcid.org/0000-0003-0306-0976
Hamid Sharif KhanRawalpindi Institute of Cardiology, Rawalpindi 46000, Pakistan.
Xiaomei GuoTongji Hospital, Huazhong University of Science and Technology, Wuhan 430030, China.
Tahir SaghirNational Institute of Cardiovascular Diseases of Pakistan, Karachi 75510, Pakistan.
Jing ChenPeople's Hospital of Wuhan University, Wuhan 430060, China.
Badar Ul Ahad GillPervez Ilahi Institute of Cardiology, Lahore 54000, Pakistan.
Ning GuoThe First Affiliated Hospital of Xi'an Jiaotong University, Xi'an 710061, China.
Imad SheibanPederzoli Hospital, Peschiera del Garda, Verona 37019, Italy.ORCID https://orcid.org/0000-0002-3694-5159
Fei YeNanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
Junjie ZhangNanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.
Feng ChenSchool of Public Health, Nanjing Medical University, Nanjing 211166, China.
Yongyue WeiCenter for Public Health and Epidemic Preparedness and Response, Peking University, Beijing 102627, China.ORCID https://orcid.org/0000-0002-9378-8794
Gregg W StoneIcahn School of Medicine at Mount Sinai, New York, NY 10029, USA.
Shao-Liang ChenNanjing First Hospital, Nanjing Medical University, Nanjing 210006, China.ORCID https://orcid.org/0000-0002-3887-952X

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Aims: The IVUS-ACS trial demonstrated that intravascular ultrasound (IVUS) guidance reduces target-vessel failure (TVF) in patients with acute coronary syndromes (ACSs) undergoing percutaneous coronary intervention (PCI). Whether this benefit applies to all ACS patients across the spectrum of risk is unknown. We sought to develop a new risk score for 1-year TVF after PCI in ACS and determine whether IVUS guidance compared with angiography guidance improves outcomes in both high- and low-risk patients. Methods and results: From the angiography-guided group of the IVUS-ACS trial ( Conclusion: The TVF-ACS risk score reliably stratifies ACS patients undergoing PCI into high- and low-risk groups. The benefits of IVUS guidance during PCI are most pronounced in high-risk ACS patients, although all ACS patients are likely to benefit.

Indexed as

Acute coronary syndromeDrug-eluting stentPercutaneous coronary interventionRisk stratificationTarget-vessel failure

Identifiers

PMID41262724
PMCPMC12625814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.